Related Experiment Video
Updated: Aug 22, 2026

A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
Published on: April 13, 2010
Bronchial hyperresponsiveness in children with atopic rhinitis: a 7-year follow-up
F Cibella1, G Cuttitta, S La Grutta
1Istituto di Biomedicina e Immunologia Molecolare del C.N.R., Palermo, Italy.
Insights
Children with allergic rhinitis have high bronchial hyperresponsiveness (BHR). However, their asthma development risk is low, with normal peak expiratory flow variability, suggesting BHR in allergic rhinitis may not predict asthma.
Area of Science:
- Pediatric Allergy and Immunology
- Respiratory Medicine
- Clinical Research
Background:
- Allergic rhinitis (AR) is common in atopic individuals.
- Bronchial hyperresponsiveness (BHR) is prevalent in atopic rhinitis patients.
- BHR may indicate an increased risk for developing bronchial asthma.
Purpose of the Study:
- To evaluate BHR and atopy in non-asthmatic children with AR over 7 years.
- To determine the role of BHR and atopy in the development of asthma in this cohort.
Main Methods:
- Twenty-eight children (6-15 years) with AR were enrolled.
- Evaluated atopy via skin tests and total serum IgE.
- Assessed BHR using methacholine bronchial challenge (PD(20)FEV(1), D(RS)) and peak expiratory flow (PEF) variability.
- Follow-up assessment after 7 years using identical criteria.
Main Results:
- At baseline, 46% of children had BHR (Mch+), with normal PEF variability.
- No children with a negative methacholine test developed asthma.
- After 7 years, only 2 of 13 children with BHR reported asthma symptoms.
Conclusions:
- Children with allergic rhinitis exhibit a high prevalence of BHR.
- Despite BHR, peak expiratory flow variability remains normal in these children.
- The rate of asthma development in children with allergic rhinitis and BHR is low.
Background:
A high prevalence of bronchial hyperresponsiveness (BHR) was found in atopic subjects with rhinitis. Those subjects may be at higher risk for developing bronchial asthma. We evaluated, in a 7-year follow-up, BHR and atopy in a homogeneous population of nonasthmatic children with allergic rhinitis (AR), and their role in asthma development.
Methods:
Twenty-eight children (6-15 years) with AR were studied. At enrollment (T(0)), skin tests, total serum IgE assay, peak expiratory flow (PEF) monitoring and methacholine (Mch) bronchial challenge were performed. BHR was computed as the Mch dose causing a 20% forced expiratory volume (FEV)(1) fall (PD(20)FEV(1)) and as dose-response slope (D(RS)). Subjects were reassessed after 7 years (T(1)) using the same criteria.
Results:
At T(0), 13 children (46%), showing a PD(20)FEV(1) <1526 microg of Mch, had BHR (Mch+), although PEF variability (PEFv) was within normal limits. None of the children with negative methacholine test developed bronchial asthma after 7 years. Of the 13 Mch+, only two reported asthma symptoms after 7 years. No significant change was seen in the other parameters of atopy considered.
Conclusion:
Children with allergic rhinitis present a high prevalence of BHR. Nevertheless, their PEFv is normal and the rate of asthma development low.
Related Concept Videos
Asthma I: Introduction
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma III: Clinical Manifestations
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-I: Introduction

